期刊文献+

临床药师对多重耐药细菌及泛耐药细菌感染的脑卒中患者的会诊方案的疗效评价 被引量:4

Evaluation the efficacy of pharmacist consultation program on the patients of stroke with infected multiple drug-resistant bacteria and the pan-drug-resistant bacteria
原文传递
导出
摘要 目的评价临床药师针对脑卒中合并多重耐药及泛耐药细菌感染患者的会诊方案的可行性与有效性。方法回顾性纳入2011-10—2014-06在遵义医学院附属医院接受临床药师会诊的脑卒中合并耐药性细菌感染患者11例,评估会诊治疗方案的接受率、疗效及细菌清除率。结果医师对临床药师会诊治疗方案的接受率为90.91%;完全接受会诊治疗方案的不同耐药性细菌感染患者治疗后的总有效率为100%;细菌清除率为87.50%。结论临床药师会诊治疗方案对多重耐药及泛耐药细菌感染疾病的预防及治疗是可行的。 Objective To investigate the effects of drug selection com-ments proposed by the clinical pharmacists during the consultation of stroke patients with multi-drug and pan-drug resistant bacterial infec-tion on the infection control and clinical efficiency.Methods Eleven stroke patients with multi-drug and pan-drug resistant bacterial infec-tion received consultation from October 2011 to June 2014 in our hospital were included in this retrospective analysis.The clinical pharmacists in-volved in the analysis of pathogenic bacteria distribution, drug resist-ance, establishing of treatment strategy, and evaluation of the clinical ef-ficiencies.Results Clinical pharmacists opinions medication acceptance rate was 90.91%.Infection in patients with the total effective rate was 100%.The bacterial eradication rate was 87.50%.Conclusion The drug selection comments proposed by the clinical pharmacists during the consultation were prime importance to the infection control and clinical efficiency of stroke patients with multi -drug and pan -drug resistant bacterial infection.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2014年第11期1036-1038,共3页 The Chinese Journal of Clinical Pharmacology
基金 教育部长江学者和创新团队发展计划项目基金资助项目(IRT1197)
关键词 临床药师 脑卒中 多重耐药细菌 泛耐药细菌 药学会诊 疗效评价 clinical pharmacist stroke multiple drug resistancebacteria pan resistant bacteria pharmacy consultation efficacy assessment
  • 相关文献

参考文献9

二级参考文献37

  • 1张樱,陈亚岗,杨青.不动杆菌感染及耐药机制的研究进展[J].国外医学(流行病学.传染病学分册),2005,32(2):109-112. 被引量:93
  • 2Driscoll JA, Brody SL, Kollef MH. The epidemiology, path- ogenesis and treatment of Pseudomonas aeruginosa infections[J]. Drugs,2007,67(3) : 351-368.
  • 3Wood GC,Hanes SD,Boucher BA,et al.Fabian TCTetracyclines of treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia[J]. Intensive Care Med,2003,29 (11):2072-2074.
  • 4Todd Gleeson,Kyle Petersen and John Mascola.Successful treatment of Acinetobacter meningitis with meropenem and rifampicin[J].J AntimicrobChemother,2005,56 (3):602-603.
  • 5Maria E.Pachón-Ibá(n)ez,Felipe Femández-Cuenca,Fernando Docobo-Pérez.Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model,using rifampicin associated with imipenem or sulbactam[J].J of AntimicrobChemother,2006,58 (3):689-692.
  • 6Gordon NC,Wareham DW.Multidrug-resistont Acinetobacter baumannii:meehanisms of virulence and resistance[J] .Int J Autimicrob Agents,2010;35(3):219-226.
  • 7Morgandj,weis enberg SA,Augenbraun MH,et al.Multidrug-resistont Acinetobacter baumannii in new York city-10 Years into the epidemic[J].lnfeet eontro| Hosp Epidemiol,2009;30(2):196-197.
  • 8杨世杰药理学[M].第1版.北京:人民卫生出版社2005,429.
  • 9Falagas ME,Maraki S,Karaseorgoponlos DE,et al.Autimicrobial Susceptibility of multidrug-resistont.(MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin[J].Int J Antimicrob Agents,2010;35(3):240-243.
  • 10陈文科,孙长贵.实用临床微生物检验与图谱[M].北京:人民卫生出版社,2011:403-407.

共引文献32

同被引文献22

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部